Placebo Response in Moderate-to-Severe Psoriasis: Prevalence Meta-Analysis of Randomized Controlled Trials
- 20 December 2022
- journal article
- letter
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 143 (6) , 1101-1104
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- Meta‐analysis results do not reflect the real safety of biologics in psoriasis*British Journal of Dermatology, 2020
- Research Techniques Made Simple: Workflow for Searching Databases to Reduce Evidence Selection Bias in Systematic ReviewsJournal of Investigative Dermatology, 2016
- Metaprop: a Stata command to perform meta-analysis of binomial dataArchives of Public Health, 2014
- Random effects meta-analysis of event outcome in the framework of the generalized linear mixed model with applications in sparse dataStatistics in Medicine, 2010
- How Good Are Clinical Severity and Outcome Measures for Psoriasis?: Quantitative Evaluation in a Systematic ReviewJournal of Investigative Dermatology, 2010
- A study examining inter- and intrarater reliability of three scales for measuring severity of psoriasis: Psoriasis Area and Severity Index, Physician's Global Assessment and Lattice System Physician's Global AssessmentBritish Journal of Dermatology, 2006
- The Course of Chronic Plaque-Type Psoriasis in Placebo Groups of Randomized Controlled StudiesArchives of Dermatology, 2004
- How should meta‐regression analyses be undertaken and interpreted?Statistics in Medicine, 2002
- Quantifying heterogeneity in a meta‐analysisStatistics in Medicine, 2002
- Placebos, Placebo Effect, and the Response to the Healing Situation: The Evolution of a ConceptEpilepsia, 2001